Acute renal failure and cardiac arrhythmias associated with remdesivir use in patients with COVID-19 infections: Analysis using the US FDA adverse event reporting system
Published in
International Journal of Risk & Safety in Medicine, January 2023
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2026.
All research outputs
#21,768,412
of 27,536,871 outputs
Outputs from International Journal of Risk & Safety in Medicine
#174
of 214 outputs
Outputs of similar age
#353,077
of 499,109 outputs
Outputs of similar age from International Journal of Risk & Safety in Medicine
#9
of 15 outputs
Altmetric has tracked 27,536,871 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 214 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 28.4. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 499,109 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
